Thirona’s LungQ 3.0.0, FDA-cleared AI software, elevates thoracic CT analysis. Automatically segmenting pulmonary structures, aids clinicians in precise diagnosis, treatment planning, and follow-up for lung diseases. With its roots in a decade of trials…
Continue Reading
What You Should Know:
– Thirona, a pioneer in AI-powered lung analysis, received a major boost for its cutting-edge technology LungQ™ with the U.S. Food and Drug Administration (FDA) 510(k) clearance for its latest update,…
Continue Reading
Thirona, a global company specializing in advanced analysis of thoracic CT images with artificial intelligence, is thrilled to announce the successful completion of its new investment. The Company has secured €7.5 Million ($8 Million)…
Continue Reading
